tiprankstipranks
Monte Rosa announces global license agreement with Novartis
PremiumThe FlyMonte Rosa announces global license agreement with Novartis
26d ago
Monte Rosa Therapeutics presents preclinical data at ENA 2024
Premium
The Fly
Monte Rosa Therapeutics presents preclinical data at ENA 2024
1M ago
Monte Rosa Therapeutics announces first participants dosed in MRT-6160 study
Premium
The Fly
Monte Rosa Therapeutics announces first participants dosed in MRT-6160 study
3M ago
Monte Rosa Therapeutics reports Q2 EPS (43c), consensus (54c)
PremiumThe FlyMonte Rosa Therapeutics reports Q2 EPS (43c), consensus (54c)
4M ago
These 2 ‘Strong Buy’ Penny Stocks Could Jump at Least 300%, Says Piper Sandler
Premium
Stock Analysis & Ideas
These 2 ‘Strong Buy’ Penny Stocks Could Jump at Least 300%, Says Piper Sandler
5M ago
Monte Rosa Therapeutics Reports Progress on Drug Development
Premium
Company Announcements
Monte Rosa Therapeutics Reports Progress on Drug Development
5M ago
Monte Rosa Therapeutics presents data at DDW 2024 on MRT-6160
PremiumThe FlyMonte Rosa Therapeutics presents data at DDW 2024 on MRT-6160
6M ago
Monte Rosa Therapeutics 10.6M share Spot Secondary priced at $4.70
Premium
The Fly
Monte Rosa Therapeutics 10.6M share Spot Secondary priced at $4.70
6M ago
Monte Rosa prices 10.6M shares at $4.70 in underwritten public offering
Premium
The Fly
Monte Rosa prices 10.6M shares at $4.70 in underwritten public offering
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100